Decrease of Libido of Post-Operative Male-Female Transsexuals and a Healthy Female Control Group

Participants fill out a questionnaire on libido and their possible partner relationship.

A blood sample is taken for sex steroid analysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Transsexualism Behavior Sexual Behavior Sexuality

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

University Hospital Ghent

Ghent, 9000, Belgium

About this study

Participants fill out a questionnaire on libido and their possible partner relationship on the website http://www.onderzoek-libido.be.

A blood sample is taken for sex steroid analysis. The relation will be investigated between testosterone, free testosterone, sex hormone binding globulin, estradiol, DHEA and androstenedione and scores on relational and sexual satisfaction and sexual desire.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Transsexual women with completed adaptation of the sex (all surgical procedures and hormonal treatments)
The female control group must be 18-45 years

Treatment and study plan

Filling out a questionnaire on libido and possible partner relationship

Procedure

Sex steroid analysis

Procedure

Sponsors and collaborators

Lead sponsor

University Hospital, Ghent

Other

Collaborators

Organon

Registry information

Important dates

Study start: 2004
Study completion: 2005
First posted: Aug 25, 2005
Registry last updated: Dec 28, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed